awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42770955-324057D8-5017-42DB-98FA-4D3F8E8A358F
Q42770955-324057D8-5017-42DB-98FA-4D3F8E8A358F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-324057D8-5017-42DB-98FA-4D3F8E8A358F
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
P2860
Q42770955-324057D8-5017-42DB-98FA-4D3F8E8A358F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42770955-324057D8-5017-42DB-98FA-4D3F8E8A358F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
830bab48ca3b76986406b17640a40b7d40afa6e9
P2860
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.